LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801

Sapna P. Patel, Megan Othus, Paul Wright, John Hyngstrom, Christopher D. Lao, T-G. Truong, Sunandana Chandra, Kari Kendra, Craig Devoe, Aparna Hegde, Ankit Mangla, Michael Lowe, Elizabeth I. Buchbinder, John M. Kirkwood, Elad Sharon, Larissa A. Korde, James Moon, Vernon K. Sondak, Antoni Ribas, Víctor G. Prieto